Uzbekistan Says 18 Youngsters Deaths Linked To India-Made Cough Syrup Doc-1 Max


Uzbekistan Cough Syrup Deaths: India is ready to probe the claims.

New Delhi:

Uzbekistan has claimed that not less than 18 youngsters within the nation have died after allegedly taking an India-manufactured cough syrup.

India is ready to probe the claims. 

The well being ministry of Uzbekistan, in a press release, mentioned that the youngsters who died had consumed cough syrup Doc-1 Max – manufactured by Noida-based Marion Biotech.

The laboratory checks of a batch of syrups discovered the presence of ethylene glycol, a poisonous substance, the ministry mentioned.

It additionally mentioned the syrup was given to youngsters at house and not using a physician’s prescription, both by their dad and mom or on the recommendation of pharmacists, with doses that exceeded the usual dose for kids.

It was discovered that the youngsters, earlier than being hospitalised, took this syrup at house for 2-7 days, in doses of two.5 to five ml three to 4 occasions a day, which exceeds the usual dose, the ministry mentioned.

The syrup was utilized by the dad and mom as an anti-cold treatment. 

After the deaths of 18 youngsters, Doc-1 Max tablets and syrups have been withdrawn from all pharmacies within the nation, the assertion mentioned, including that seven workers have been sacked as a result of they did not analyse the scenario in time and take steps.

A joint inquiry shall be performed by the groups of Central Medicine Customary Management Organisation  (CDSCO – north zone) and Uttar Pradesh Medicine Controlling and Licensing Authority, it’s learnt. 

A casualty evaluation report has additionally been sought from Uzbekistan.

That is the second time in a yr that India-manufactured cough syrups have come underneath the scanner.

Earlier this yr, deaths of 70 youngsters in Gambia have been linked to cough syrups manufactured by Haryana-based Maiden Prescribed drugs. 

The Central Medicine Customary Management Organisation had in October shut its unit in Sonepat for violation of producing requirements.

The WHO had earlier mentioned that laboratory evaluation of Maiden cough syrup had confirmed “unacceptable” quantities of diethylene glycol and ethylene glycol, which might be poisonous and result in acute kidney harm.

Responding to WHO, Medicine Controller Common, VG Somani, had mentioned that checks on samples of Maiden’s merchandise at authorities laboratories had “been discovered to be complying with specs” and no poisonous substance was detected in them.


Please enter your comment!
Please enter your name here